The risk increases with higher cumulative doses, previous cardiovascular disease, and concurrent use of other cardiotoxic medications. Studies indicate that up to 26% of patients receiving ...

report that this drug can be cardiotoxic, causing severe left ventricular ... patients on imatinib should be watched for heart problems. Other drugs currently being developed to target c-Abl ...

As a result, cancer patients, particularly those who have been prescribed cardiotoxic drugs, can be closely monitored to identify and manage their risk factors for CVD, alter treatment strategies ...

has designed a strategy for preventing the cardiotoxic effects of anthracyclines, a widely used class of anticancer drugs. Cardiotoxicity is a frequent adverse secondary effect of cancer therapy ...

If there is a cardiotoxic drug, we make sure patients ... issues that are getting denied and can't get access to the medication. We can also help our providers figure out what our formulary ...